title: Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
authors: Paulo S L
authors: PS
authors: da Silva
authors: Roselene M A
authors: RM
authors: Passos
authors: Daniel R
authors: DR
authors: Waisberg
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D002697:Chloral Hydrate / Q000009:adverse effects*; D003000:Clonidine / Q000627:therapeutic use*; D005283:Fentanyl / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D015931:Intensive Care, Neonatal; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008874:Midazolam / Q000009:adverse effects / Q000627:therapeutic use; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000150:complications / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D000316:Adrenergic alpha-Agonists; D000701:Analgesics, Opioid; D006993:Hypnotics and Sedatives; D002697:Chloral Hydrate; D003000:Clonidine; D008140:Lorazepam; D008874:Midazolam; D008691:Methadone; D005283:Fentanyl